Corbus Pharmaceuticals Holdings, Inc. Payments to Acquire Marketable Securities
Corbus Pharmaceuticals Holdings, Inc. (CRBP) reported Payments to Acquire Marketable Securities of $77.27 million for the 9-month period ending 2021-09-30, per its 10-Q filed 2021-11-12.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireMarketableSecurities · last filed 2021-11-12
- Corbus Pharmaceuticals Holdings, Inc. payments to acquire marketable securities for the quarter ending 2021-09-30 was $6.74M.
- Corbus Pharmaceuticals Holdings, Inc. payments to acquire marketable securities for the quarter ending 2021-06-30 was $13.10M.
- Corbus Pharmaceuticals Holdings, Inc. payments to acquire marketable securities for the quarter ending 2021-03-31 was $57.43M.
| Period end | Payments to Acquire Marketable Securities 3 month | Payments to Acquire Marketable Securities 6 month | Payments to Acquire Marketable Securities 9 month |
|---|---|---|---|
| 2021-09-30 | $6.74M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | $19.84M derived: sum of 2 quarters · filed 2021-11-12 | $77.27M 10-Q · filed 2021-11-12 |
| 2021-06-30 | $13.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $70.53M 10-Q · filed 2021-08-12 | |
| 2021-03-31 | $57.43M 10-Q · filed 2021-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |